Remedy Health buys HealthCentral

Share this article:

Health information site HealthCentral has been acquired by Remedy Health, a multimedia provider of content and tools designed to help people manage disease, the firms announced.

Terms of the deal were not disclosed by the companies, both of which are owned by private investors.

HealthCentral's network of bloggers and expert patients in a variety of topic areas supplements the digital side of the Remedy media portfolio, which spans mobile, print and point-of-care information and technology products.

According to data from comScore, HealthCentral drew 3.2 million unique visitors in October. Remedy's online traffic figures were not immediately available.

“With the acquisition of HealthCentral, we've dramatically increased our online reach, sales capacity and our ability to create industry-leading health information and technology applications,” stated Mike Cunnion, CEO of Remedy. “The combination creates exciting opportunities to provide even more value to our audiences, customers and strategic partners.”

Remedy says an internal audit shows that its expanded reach now includes 23 million unique monthly visitors to its health information websites—the combined total of the two firms' online health properties.

Remedy already reaches more than 17 million patients and caregivers at pharmacy counters nationwide through magazines and newsletters, has a 20-million member customer database, and keeps a network of more than 600,000 physicians, it said.

HealthCentral CEO Chris Schroeder will remain involved in the business as a consultant to Remedy and the board of directors. He has also been named an advisor to Polaris Ventures, one of a number of HealthCentral investors. Remedy is owned by private investment firm Veronis Suhler Stevenson (VSS).
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"